Related Experiment Video

Updated: Aug 12, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Worldwide guidelines for respiratory tract infections: community-acquired pneumonia

K Dalhoff1

  • 1Medical Clinic, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.

International Journal of Antimicrobial Agents
|September 28, 2001
PubMed

Insights

Managing respiratory infections is complex due to antibiotic resistance. Clinical guidelines exist, but optimal care for community-acquired pneumonia (CAP) requires ongoing evaluation to ensure current recommendations remain effective.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • Respiratory tract infections (RTIs) pose significant management challenges.
  • Rising bacterial resistance and antibiotic misuse necessitate evidence-based treatment strategies.
  • Existing clinical guidelines aim to standardize RTI management, yet consensus on optimal care for lower RTIs remains elusive.

Purpose of the Study:

  • To review the evolution and necessity of clinical guidelines for respiratory tract infections.
  • To highlight the ongoing need for re-evaluation of community-acquired pneumonia (CAP) management guidelines.
  • To address the lack of consensus on optimal care for lower respiratory tract infections.

Main Methods:

  • Review of existing literature and clinical guidelines for respiratory tract infections.
  • Analysis of historical development of community-acquired pneumonia (CAP) guidelines since the 1990s.
  • Discussion on the principles of guideline re-evaluation in infectious disease management.

Main Results:

  • Clinical guidelines for RTIs have been developed in response to antibiotic resistance concerns.
  • Despite guideline development, optimal care for lower respiratory tract infections is not universally agreed upon.
  • Community-acquired pneumonia (CAP) guidelines have been established in North America and Europe since the 1990s.

Conclusions:

  • Effective management of RTIs requires adherence to evolving clinical guidelines.
  • Continuous re-evaluation of CAP guidelines is crucial to maintain their relevance and efficacy.
  • Achieving consensus on lower RTI treatment remains a critical objective in respiratory medicine.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...